Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNMSF | AMGN | GILD | CELG | VRTX |
| Company | Genmab A/S | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 292.3600 | 312.89 | 64.72 | 108.01 | 420.67 |
| High | 292.3600 | 313.99 | 65.64 | 108.59 | 420.67 |
| Low | 292.3600 | 310.87 | 64.67 | 107.27 | 417.65 |
| Last | 292.3600 | 313.28 | 65.42 | 108.24 | 419.85 |
| Change | +7.9100 | +0.42 | +0.84 | +0.11 | +0.86 |
| % Change | +2.78% | +0.13% | +1.30% | +0.10% | +0.21% |
| Volume | 70 | 654,766 | 1,914,163 | 191,230,496 | 150,450 |
| 20-Day Average Volume | 584 | 2,825,771 | 7,252,599 | 16,188,930 | 1,059,884 |
| Previous Close | 284.4500 | 312.86 | 64.58 | 108.13 | 418.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 282.3925 | 281.69 | 65.95 | 108.17 | 401.69 |
| 20-Day Raw Stochastic | 75.03% | 82.65% | 19.39% | 63.25% | 77.12% |
| 20-Day Relative Strength | 52.34% | 67.24% | 35.21% | 64.69% | 58.92% |
| Weighted Alpha | -27.43 | +35.05 | -20.69 | +46.30 | +20.92 |
| Today's Opinion | 72% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 56% Buy | 100% Sell | 100% Buy | 56% Buy |
| Last Month's Opinion | 40% Sell | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.90% since 05/03/24 | +0.18% since 05/03/24 | +0.54% since 05/03/24 | -1.97% since 11/13/19 | +4.15% since 05/03/24 |
| Low | 274.1600 on 05/08/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 107.27 on 11/20/19 | 394.03 on 05/07/24 |
| High | 296.5900 on 05/06/24 | 314.60 on 05/09/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -1.81% since 04/10/24 | +17.04% since 04/10/24 | -4.39% since 04/10/24 | +5.14% since 10/18/19 | +5.07% since 04/10/24 |
| Low | 265.3000 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 306.1700 on 04/11/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 110.70 on 11/13/19 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | +6.51% since 02/09/24 | +7.12% since 02/09/24 | -11.59% since 02/09/24 | +13.63% since 08/20/19 | -1.23% since 02/09/24 |
| Low | 262.0000 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 323.0180 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -5.87% since 11/10/23 | +16.66% since 11/10/23 | -14.21% since 11/10/23 | +14.14% since 05/20/19 | +11.80% since 11/10/23 |
| Low | 262.0000 on 02/13/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 334.3280 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,594,498 | 167,829,040 | 80,407,072 | 77,035,920 | 108,121,632 |
| Shares Outstanding, K | 65,370 | 536,435 | 1,245,077 | 711,714 | 258,053 |
| Annual Sales | 2,392,030,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 631,910,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 603,220,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 192,920,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.05 | 0.60 | 0.22 | 1.41 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.94 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.46 | 16.50 | 16.11 | 10.99 | 27.81 |